The core activity of Celerion is the conduct of clinical trials and services for the pharmaceutical industry, particularly in the areas of: Early Phase Services, Clinical Trial Design, Project Management, Clinical Monitoring, Medical Monitoring, Bioanalytical Sciences, Pharmacokinetics and Pharmacodynamics (PK/PD), Immunogenicity and Biomarkers, Biosimilars and Gene Therapy, Metabolite Profiling, Drug Development and Regulatory Affairs, Data Management and Biometrics, Modeling and Simulation, Protocol Development, Clinical Data Sciences, Biostatistics, and Medical Writing and Reporting. The company offers these services across various therapeutic areas, including respiratory diseases, metabolic disorders, oncology, biosimilars, vaccines, renal and hepatic insufficiency, and cardiovascular safety studies.